TODD S. THOMSON - 22 May 2025 Form 4 Insider Report for ACTUATE THERAPEUTICS, INC. (ACTU)

Role
Director, 10%+ Owner
Signature
/s/ Paul Lytle, Attorney-in-Fact
Issuer symbol
ACTU
Transactions as of
22 May 2025
Net transactions value
$0
Form type
4
Filing time
23 May 2025, 16:37:19 UTC
Previous filing
16 Aug 2024
Next filing
07 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
THOMSON TODD S Director, 10%+ Owner C/O ACTUATE THERAPEUTICS, INC., 1751 RIVER RUN, SUITE 400, FORTH WORTH /s/ Paul Lytle, Attorney-in-Fact 23 May 2025 0001225707

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACTU Stock Options Award $0 +15,000 $0.000000 15,000 22 May 2025 Common Stock 15,000 $10.10 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options will vest in full on the anniversary of the grant date.
F2 Todd Thomson serves as Chief Financial Officer/Chief Operating Officer of Kairos Venture Investments, LLC ("KVI"), and serves on the board of directors (the "Board") of Actuate Therapeutics, Inc. ("Actuate"). Mr. Thomson has advised Actuate that he serves on the Board as a representative of certain funds managed and controlled by KVI (the "Kairos Funds") and because Mr. Thomson serves on the Board as a representative of the Kairos Funds, certain of the Kairos Funds have a right to an economic interest in the securities of Actuate granted to Mr. Thomson in respect of his Board position and such Kairos Funds are entitled to an indirect pecuniary interest in such securities, including the Stock Options reported on this Form 4.

Remarks:

Exhibit 24 - Power of Attorney